HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tuberin and p27 expression in breast cancer patients with or without BRCA germline mutations.

AbstractBACKGROUND:
Tuberin, the protein product of tuberous sclerosis gene 2 (TSC2), is the functional component of the TSC1/TSC2 complex and regulates cell cycle through activation of the cyclin-dependent kinase inhibitor p27. The transcriptional regulation of p27 is, however, also linked to a functional BRCA protein, since in BRCA1 mutant breast cancer cells, which lack the ability to repair DNA damages by homologous recombination, p27 is down-regulated. We have therefore investigated the expression of both tuberin and p27 in normal breast tissue, and in malignant epithelium from women with and without a BRCA mutation.
MATERIALS AND METHODS:
immunohistochemistry was used to compare p27 and tuberin protein expression in 26 BRCA1 and 2 mutation carriers, in 53 matched breast cancer patients without a family history, and in 74 benign breast tissues in a case-control study.
RESULTS:
Tuberin and p27 protein expression were significantly more common in benign when compared to malignant breast tissue (p = 0.01 and p = 0.03), but no difference was observed when sporadic and BRCA-mutated breast cancer specimen were compared. Tuberin and p27 were positively correlated with each other (p = 0.0017, r = 0.2527). Furthermore, p27 expression was positively correlated with ER and PR, and negatively correlated with tumor size. The expression of tuberin and p27 in breast cancer was not correlated with clinical outcome.
CONCLUSION:
Our results suggest that tuberin and p27 are aberrantly expressed in malignant tissue, but their expression does not appear to be dependent on the BRCA mutation state of a breast cancer patient.
AuthorsAnne Catharina Dressler, Gernot Hudelist, Anneliese Fink-Retter, Daphne Gschwantler-Kaulich, Georg Pfeiler, Margit Rosner, Markus Hengstschläger, Christian F Singer
JournalJournal of cancer research and clinical oncology (J Cancer Res Clin Oncol) Vol. 139 Issue 8 Pg. 1349-55 (Aug 2013) ISSN: 1432-1335 [Electronic] Germany
PMID23689538 (Publication Type: Journal Article)
Chemical References
  • Proliferating Cell Nuclear Antigen
  • TSC2 protein, human
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Proteins
  • p27 antigen
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms (genetics, metabolism)
  • Case-Control Studies
  • Female
  • Genes, BRCA1
  • Germ-Line Mutation
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Proliferating Cell Nuclear Antigen (analysis, biosynthesis)
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Proteins (analysis, biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: